Stroke Trial, Recruiting NCT06380049 Sponsor: Seoul National University Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06380049
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

For people who have had a stroke:

Who might be able to join this trial:

  • People aged 19 years or older
  • People whose stroke happened less than 3 months ago
  • People who have leg weakness caused by their stroke (at a specific level of weakness measured by a standard muscle test)
  • People who are able to understand and follow instructions

Who may not be able to join:

  • People who have had more than one stroke
  • People who have other nervous system conditions (such as Parkinson's disease)
  • People with severely impaired thinking or memory
  • People with serious or complex medical conditions (such as active cancer)
  • People who have a cardiac pacemaker or any other implanted electronic device

For healthy participants:

Who might be able to join this trial:

  • People aged 19 years or older
  • People who fully understand the purpose of the study and have chosen to take part voluntarily

Who may not be able to join:

  • People who have other nervous system conditions (such as Parkinson's disease)
  • People with severely impaired thinking or memory
  • People with serious or complex medical conditions (such as active cancer)
  • People who have a cardiac pacemaker or any other implanted electronic device

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Woo Hyung Lee, prof, Seoul National University Hospital

Phone: 82+1088632341

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 May 2024
Est. completion
12 March 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Sensitivity of the Machine Learning Model

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov